Medicines in Development for Leukemia and Lymphoma – Webinar

Date(s) - 29 Apr 2013
10:00 AM - 11:00 AM


PhRMA is committed to advancing our mission of research, progress and hope.

April’s webinar will focus on the research and progress that has been made toward finding a cure
for Leukemia and Lymphoma.

The report: Medicines in Development for Leukemia and Lymphoma, just released, found there are 241 medicines currently in clinical trials or under review by the FDA to treat blood cancers. And, as a result of our continued progress, survival rates for those with non-Hodgkin Lymphoma have increased from 40% in the early 1960s to 86% in 2007.

Read the report and learn more about the progress we’re making.

Learn more at the PhRMA Webinar :

Monday, April 29 at 1 p.m. EDT 10 AM AZ

PhRMA will host a live panel discussion to discuss the exciting research underway, potential challenges to future progress and the importance of partnerships in medical innovation.

The event features

  • Dr. Rick Winneker, Senior Vice President, Research, at the Leukemia & Lymphoma Society (LLS)
  • Dr. Joe Camardo, Senior Vice President, Global Medical Affairs at Celgene
  • Jessica Melore, a blood cancer survivor
  • Salvo Alesci, Vice President, Scientific and Regulatory Affairs at PhRMA.

Watch the webcast live at: